Mabion Launches €500,000 Services Contest to Support Next-Gen Oncology Advances

Mabion Launches €500,000 Services Contest to Support Next-Gen Oncology Advances

Mabion, a CDMO based in Poland, launched a €500,000 ($574,000) oncology services contest at the BIO International Convention aimed at accelerating the development of recombinant protein-based cancer therapies. The contest will culminate at CPHI Worldwide in Frankfurt this October, spotlighting promising biotechs ready to scale their innovation. “Despite unprecedented scientific advances, many oncology treatments still face hurdles at the funding…

Mabion launches €500,000 services contest to support oncology breakthroughs  - European Biotechnology Magazine

Lodz-based CDMO Mabion SA has launched a €500,000 oncology services contest at BIO International Convention 2025, aimed at accelerating the development of recombinant protein-based cancer therapies. The contest will culminate at CPHI Worldwide in Frankfurt this October, spotlighting promising biotechs ready to scale their innovation. The post Mabion launches €500,000 services contest to support oncology breakthroughs  appeared first on European …